Cambridge Scholars Highlight Potential

Scholars from the University of Cambridge found that 1-methylΨ modification can lead to +1 frameshifting and off-target T-cell immune responses, suggesting a potential "defect" in mRNA vaccine technology.

Dec 28, 2023

Read More

Non-coding Sequences Matter for Cancer Immunotherapy| GenScript

Non-coding sequences also play a significant role, as scholars from Sun Yat-sen University may develop a novel cancer immunotherapy from them.

Nov 29, 2023

Read More

Revolutionizing Genome Editing with Compact and Efficient Prime Editors | GenScript

Scientists are revolutionizing genome editing with Phage-Assisted Continuous Evolution (PACE), creating compact, efficient prime editors.

Oct 07, 2023

Read More

COURIER: A Novel Engineered RNA Output System for Cell Analysis and Therapy | GenScript

Caltech researchers developed an engineered RNA output system called COURIER as a new tool for cell biology and medical research.

Aug 27, 2023

Read More

PSME4, a Critical Player in the Battle against Cancer | GenScript

Researchers find a proteasome regulator that influences proteasome activity and antigen diversity, weakening antitumor immunity.

Jul 17, 2023

Read More

Personalized mRNA Vaccines to Fight Pancreatic Cancer

Researchers develop personalized mRNA vaccines based on each patient's genetic makeup to fight pancreatic cancer.

Jun 19, 2023

Read More

Scientists Reveal an Important Mechanism for Antibody Immunity

Researchers are investigating why antibodies seem to recognize certain parts of antigens more readily than others.

May 25, 2023

Read More

Finely Downregulate Gene Expression and Modulate Plant Phenotypes | GenScript

A new method was developed to predictably and finely down-regulate the protein expression of target genes.

Apr 19, 2023

Read More

< 1 2 3 4 5 6 > Total Pages 6